scholarly journals Chronic SARS-CoV-2, a Cause of Post-acute COVID-19 Sequelae (Long-COVID)?

2021 ◽  
Vol 12 ◽  
Author(s):  
Jake S. O’Donnell ◽  
Keith J. Chappell

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the cause coronavirus disease 2019 (COVID-19). Most individuals recover from SARS-CoV-2 infection, however, many continue to experience a cluster of persistent symptoms for months following resolution of acute disease; a syndrome that has been named Long-COVID. While the biological cause, or causes, of Long-COVID have not yet been confirmed, the main proposals have centred around either virus-induced autoimmunity or virus-induced tissue dysfunction. However, an alternative suggestion that a latent chronic infection could be responsible for the symptoms of Long-COVID has received minimal attention despite recent findings that SARS-CoV-2 genetic material and infections are detected in some individuals months following resolution of respiratory disease. Here we discuss literature supporting the possibility that Long-COVID occurs as a result of chronic SARS-CoV-2 infections.

2018 ◽  
Vol 11 (3) ◽  
pp. 149-154
Author(s):  
Eman Gaballah ◽  
Aida Abdel-Magied ◽  
Nora Aboulfotouh ◽  
Goman Elganainy

2004 ◽  
Vol 20 (2) ◽  
pp. 76-80 ◽  
Author(s):  
Hsueh-Erh Liu

Severe Acute Respiratory Syndrome (SARS) is a newly identified respiratory disease that threatened Taiwan between April 14 and July 5, 2003. Chang Gung University experienced various SARS-related episodes, such as the postponement of classes for 7 days, the reporting of probable SARS cases, and the isolation of students under Level A and B quarantines. Ninety-eight percent of the students at the university live in dormitories; thus the prevention of SARS became an important issue. Preventive strategies are classified into primary, secondary, and tertiary prevention, with a different focus and strategy for each level of prevention. The university emphasized personal hygiene and a healthy lifestyle as the key to SARS prevention. Our experiences as school nurses during this crisis can help other school nurses to prevent the spread of SARS during similar situations.


2021 ◽  
Vol 42 (2) ◽  
pp. 136-141
Author(s):  
Auddie M. Sweis ◽  
Tran B. Locke ◽  
Kevin I. Ig-Izevbekhai ◽  
Theodore C. Lin ◽  
Ankur Kumar ◽  
...  

Background: Aspirin therapy and/or type 2 (T2) biologics are used in the management of aspirin-exacerbated respiratory disease (AERD). Objective: To identify the number of patients with AERD who tolerated aspirin therapy, yet due to persistent symptoms, incorporated T2 biologic management. Methods: A retrospective review was performed between July 2016 and June 2019. Patients with AERD and who underwent endoscopic sinus surgery (ESS), aspirin desensitization (AD), and at least 6 months of aspirin therapy (ATAD) after AD, and who remained biologic-naive up through this timepoint were included in the study. Introduction of a T2 biologic while on ATAD was the primary outcome. The secondary outcome was a change in a validated patient-reported outcome measure for chronic rhinosinusitis score between the postoperative predesensitization timepoint, and the 6-month postdesensitization timepoint, presented as means and compared by using the Student's t-test. Results: A total of 103 patients met inclusion criteria. Two patients (1.9%) ultimately supplemented ATAD with a T2 biologic. The mean outcomes measure test score after 6 months of ATAD for patients who received biologics was 40.5 versus 15 in those who did not receive biologics (p = 0.02). The mean differences between the postoperative predesensitization test score and the 6-month postdesensitization test score for patients who went on to receive biologics was an increase of 13 versus a decrease of 10 for those patients who did not receive biologics (p = 0.12). Conclusion: ESS, coupled with AD and ATAD, was successful in the long-term management of the majority of the patients with AERD, which rarely required the incorporation of T2 biologics. Patient questionnaires, such as outcomes measure test score, may identify aspirin therapy failures and help guide the practitioner in deciding when to introduce T2 biologics into the patient's treatment regimen.


2021 ◽  
Vol 3 (1) ◽  
pp. 1-5
Author(s):  
Apen Hoddor Silaban

Coronavirus disease 2019 is a novel pneumonia-like respiratory disease caused by the infection of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The virus can invade the human body through various intermediaries, including through the eye. The presence of a coronavirus invasion in the eye may cause several ocular manifestations, which can be an initial clinical finding of a coronavirus infection in the host body. On the other hand, it can also cause systemic complications that may affect the eyes. This review will discuss in more detail how the coronavirus can infect humans through the eye, explain its manifestations, and briefly explain the proper and prompt management steps that must be taken.


Diagnostics ◽  
2020 ◽  
Vol 10 (3) ◽  
pp. 165 ◽  
Author(s):  
Ting Yang ◽  
Yung-Chih Wang ◽  
Ching-Fen Shen ◽  
Chao-Min Cheng

At the end of 2019, the novel coronavirus disease (COVID-19), a fast-spreading respiratory disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), was reported in Wuhan, China and has now affected over 123 countries globally [...]


2021 ◽  
Vol 33 (1) ◽  
Author(s):  
Ahmed S. Gado ◽  
Rawya A. Khater

Abstract Background On 12 December 2019, a severe respiratory disease was recently reported in Wuhan, known as COVID-19 caused by severe acute respiratory syndrome coronavirus 2. The coronavirus crisis has unequivocally had a marked influence on medical education, particularly in terms of the delivery of assessment. Institutions were forced to implement several changes to medical exam due to COVID-19 pandemic. Written exams were carried out online. Clinical exams were repeatedly canceled or postponed this year. Some institutions carried out clinical exams using remote OSCE stations or without patients. We present our experience in conducting the medical exam in the COVID-19 era. Main body Medical exam of the Egyptian Fellowship was canceled in 2020 due to COVID-19 pandemic. The candidates were disappointed and increasingly anxious. After 1 year delay, the internal medicine board decided to carry out the exam after implementing several changes. Changes included the written and clinical exams. The medical exam was successfully conduced in the COVID-19 era. Conclusion Conducting a medical exam in the COVID-19 era carries a great challenge for the institutions. Institutions should allow for some degree of flexibility when carrying out exams to prevent suffering of the candidates from the difficult circumstances.


2020 ◽  
Vol 3 (7) ◽  
pp. 401-403
Author(s):  
Eder Cano Pérez ◽  
Jaison Torres-Pacheco ◽  
Génesis García-Díaz ◽  
María Carolina Fragozo-Ramos

We are living in times when a viral pandemic has stopped normal life in much of the world. The new viral agent named Coronavirus 2 of the Severe Acute Respiratory Syndrome (SARS-CoV-2), was found to be the cause of the so-called Coronavirus Disease 2019 (COVID-19). This new coronavirus is closely related to other emerging zoonotic coronaviruses, such as the etiological agent of Severe Acute Respiratory Syndrome (SARS-CoV) and the Coronavirus related to the Middle East Respiratory Syndrome (MERS-CoV), which can cause disease severe in humans (1). Early symptoms in most COVID-19 patients include fever, dyspnea, cough, and sore throat, which can progress to pneumonia in severe cases. Other symptoms such as some gastrointestinal manifestations, including diarrhea, are less frequent (2). Respiratory droplets and contact transmission are considered the most important routes of transmission of COVID-19 but do not fully explain the occurrence of all cases and the rapid spread of this new virus (3). Recently, some studies have reported evidence of the presence of SARS-CoV-2 RNA in feces and wastewater, which raises the possibility of faecal-oral transmission of COVID-19. Some investigations have shown that the positivity of SARS-CoV-2 in the feces remains between 7 and 33 days after the samples of nasopharyngeal swabs were negative, increasing the possibility that the virus is transmitted through contaminated fomites (4, 5). Other studies have managed to isolate the virus present in the feces, determining the viability of the virus in these samples, showing the potential risk of faecal-oral contagion (3). Another associated intrinsic concern is the possibility of mechanical transmission of insect-mediated SARS-CoV-2. Vectors such as flies and cockroaches circulate in environments where feces are present and may carry viruses on their body and in their intestinal tract, contaminating surfaces (6). In recent months, studies have emerged where they detect the genetic material of SARS-CoV-2 in wastewater (7). However, there is still no evidence of the viability of SARS-CoV-2 in these water sources. A study conducted on SARS-CoV during the outbreak in 2003 showed that the virus remains active in running water for 10 days at 23°C, while at low temperatures of 4°C the viability of the virus can reach up to 100 days. In wastewater, the viability of the virus decreases by 99.99% between 2-3 days at temperatures ~20°C and up to 14 days at 4°C (8). Considering the above, three possible environmental routes have been proposed for faecal-oral transmission of SARS-CoV-2 in humans from the feces. Within the main routes, it is found, the water, the surfaces, and the contact with the places where the vector insects circulate. From these environments, through different routes, viruses can reach the mouth and infect the intestinal and respiratory tracts of a susceptible host (9). To date, there have been no reports of humans contracting the SARS-CoV-2 virus through faecal-oral transmission, however, this possible mechanism itself represents a potential risk for the spread and transmission of COVID-19 in the Latin American context, considering that about 191 million people are living in poverty and 72 million in extreme poverty. This means that 30.8% of Latin Americans are poor, and 11.5% are extremely poor. This supposes that part of the population does not have the necessary resources such as food, drinking water, or managed sanitation (10). Additionally, disadvantaged people are more likely to live in overcrowded accommodation, with poor housing conditions, limited access to personal outdoor space, and overcrowding, factors that increase exposure to COVID-19. In conclusion, despite the need for more studies, if the "faecal-oral hypothesis" is confirmed as a transmission mechanism for COVID-19, it may result in far-reaching consequences for public health and pandemic control, especially in regions with fragile health systems such as Latin America, so studies are required to evaluate the influence of environmental factors on COVID-19 in the region.


2021 ◽  
Vol 21 (4) ◽  
pp. 1574-83
Author(s):  
Eman A El-Masry

In the past years, numerous new fatal infections have emerged, including Ebola, Nipah, and Zika viruses, as well as coronaviruses. Recently, infections with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have emerged in China, and were then transmitted all over the world, causing the coronavirus disease-19 (COVID-19) pandemic, which is transmitted at a higher rate than other diseases caused by coronaviruses. At the time of writing this review, COVID-19 is not contained in most countries in spite of quarantine, physical distancing, and enhanced hygiene measures. In this review, I address different methods for passive and active immunization against this virus, which is known to cause fatal respiratory disease, including natural passive immunization by breast milk, natural active immunization by herd immunization, artificial passive immunization by convalescent plasma or monoclonal antibodies, and artificial active immunization by vaccination. I hope this review will help design a prophylactic approach against outbreaks and pandemics of related coronaviruses in the future. Keywords: Breastfeeding; COVID-19; herd immunity; monoclonal antibodies; SARS-CoV; vaccine.


2021 ◽  
Author(s):  
Maria Clara Carvalho Silva de Amorim ◽  
Karla Oliveira Couto ◽  
Pedro José da Silva Júnior ◽  
Thiago Gonçalves Fukuda ◽  
Pedro Antônio Pereira de Jesus ◽  
...  

Context: The novel severe acute respiratory syndrome coronavirus 2 (SARSCoV-2) emerged in Wuhan, China and rapidly spread worldwide. Although the predominant clinical presentation is with respiratory disease, neurological manifestations are being recognised increasingly. Case report: In this report, we demonstrate a case of hemispheric brain in volvement as a neurological manifestation of Sars-cov-2 in a 74-year-old patient admitted to Hospital Santa Izabel (HSI) between May and July 2020. Conclusion: In COVID-19, although the predominant clinical presentation is with respiratory disease, neurological complications have been reported. Severe neurological complications are either because of direct viral invasion, immunological reaction, or hypoxic metabolic changes. The patients with encephalitis are usually severely or critically ill.


Sign in / Sign up

Export Citation Format

Share Document